With recent development in management, pancreatic cancer has shown significant
improvement in prognosis. 1 Surgery still represents the only potentially curative treatment,
and many innovations have been suggested to improve the clinical outcome of pancreatic
cancer. 2 Hospital volume, in other words, centralization, is one of those innovations, and
several studies have reported an association between hospital volume and clinical outcome.
3, 4 However, centralization could exacerbate a potential weakness: the prolongation of …

Method: In this retrospective cohort study, a total 554 patients with pathologically confirmed
pancreatic ductal adenocarcinoma were assessed the eligibility from 2014 through 2015.
Patients with neoadjuvant chemotherapy, body-tail resection, total pancreatectomy and
combined adjacent organ resection were excluded. All patients were divided into two groups
by median waiting time, 21 days, defined as the date difference between initial imaging
diagnosis and operation. Result: Median overall survival did not differ between long and …